C-J0SDlipofuscin removal, retinal pigment epithelium, ophthalmology
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Patents are split by ownership. Held by the company are assigned to this organization. Field corridor patents are held by others in the same technical area — shown to map the freedom-to-operate landscape, not company-owned IP.
Patents assigned to this organization.
US10495630B2 - Methods for the determination of compounds or compositions for the treatment of lipofuscin related diseases and compounds or compositions - Google Patents US10495630B2 - Methods for the determination of compounds or compositi…
EP2080513A1 - Tetrahydropyridoethers for treatment of AMD - Google Patents EP2080513A1 - Tetrahydropyridoethers for treatment of AMD - Google Patents Tetrahydropyridoethers for treatment of AMD Download PDF Info Publication number EP2080513…
WO2015121441A1 - Methods for the determination of compounds or compositions for the treatment of lipofuscin related diseases and compounds or compositions - Google Patents WO2015121441A1 - Methods for the determination of compounds or compo…
CA2749754C - Tetrahydropyridoethers pour le traitement de la degenerescence maculaire liee a l'age (amd) - Google Patents CA2749754C - Tetrahydropyridoethers pour le traitement de la degenerescence maculaire liee a l'age (amd) - Goo…
US10495630B2 - Methods for the determination of compounds or compositions for the treatment of lipofuscin related diseases and compounds or compositions - Google Patents US10495630B2 - Methods for the determination of compounds or compositi…
Blocking or adjacent IP in the same technical area, owned by third parties. Not affiliated with this organization.
US20120156202A1 - Age related macular degeneration treatment - Google Patents US20120156202A1 - Age related macular degeneration treatment - Google Patents Age related macular degeneration treatment Download PDF Info Publication number US20…
EP2508182B1 - Hydralazine for use in the treatment of age-related macular degeneration - Google Patents EP2508182B1 - Hydralazine for use in the treatment of age-related macular degeneration - Google Patents Hydralazine for use in the treat…
US8158609B1 - Use of cyclodextrins as an active ingredient for treating dry AMD and solubilizing drusen - Google Patents US8158609B1 - Use of cyclodextrins as an active ingredient for treating dry AMD and solubilizing drusen - Google Patent…
WO2021165206A1 - Treatment of dry amd with integrin antagonists - Google Patents WO2021165206A1 - Treatment of dry amd with integrin antagonists - Google Patents Treatment of dry amd with integrin antagonists Download PDF Info Publication n…
US20180272009A1 - Non-human primate model of age-related macular degeneration and method for producing same - Google Patents US20180272009A1 - Non-human primate model of age-related macular degeneration and method for producing same - Googl…
CA3284985A1 - Treatment of dry age-related macular degeneration - Google Patents CA3284985A1 - Treatment of dry age-related macular degeneration - Google Patents Treatment of dry age-related macular degeneration Info Publication number CA32…
US20220257633A1 - Method of treating age-related macular degeneration - Google Patents US20220257633A1 - Method of treating age-related macular degeneration - Google Patents Method of treating age-related macular degeneration Download PDF I…
US10117931B2 - Methods for treatment of age-related macular degeneration - Google Patents US10117931B2 - Methods for treatment of age-related macular degeneration - Google Patents Methods for treatment of age-related macular degeneration Do…
WO2021091718A1 - Anti-c5 agent for treatment of dry age-related macular degeneration (amd) or geographic atrophy secondary to dry amd - Google Patents WO2021091718A1 - Anti-c5 agent for treatment of dry age-related macular degeneration (amd…
US20240139328A1 - Anti-c5 agent for treatment of dry age-related macular degeneration (amd) or geographic atrophy secondary to dry amd - Google Patents US20240139328A1 - Anti-c5 agent for treatment of dry age-related macular degeneration (a…
WO2020079464A1 - Method for treating retinal degeneration disease by administering nucleolin polynucleotide or polypeptide - Google Patents WO2020079464A1 - Method for treating retinal degeneration disease by administering nucleolin polynuc…
US20200330415A1 - Drug for retinal degenerative disease associated with photoreceptor degeneration - Google Patents US20200330415A1 - Drug for retinal degenerative disease associated with photoreceptor degeneration - Google Patents Drug for…
WO2022260939A2 - Compositions and methods for treating or preventing stargardt's disease and/or retinal binding protein 4 (rbp4)-associated disorders - Google Patents WO2022260939A2 - Compositions and methods for treating or preventing…
WO2020214809A2 - Gene therapies for stargardt disease (abca4) - Google Patents WO2020214809A2 - Gene therapies for stargardt disease (abca4) - Google Patents Gene therapies for stargardt disease (abca4) Download PDF Info Publication number…
WO2025147467A1 - 10mg to 35mg of gildeuretinol for use in the treatment of stargardt disease - Google Patents WO2025147467A1 - 10mg to 35mg of gildeuretinol for use in the treatment of stargardt disease - Google Patents 10mg to 35mg of gild…
US20220177539A1 - Gene therapies for stargardt disease (abca4) - Google Patents US20220177539A1 - Gene therapies for stargardt disease (abca4) - Google Patents Gene therapies for stargardt disease (abca4) Download PDF Info Publication numbe…
WO2024229240A2 - Compositions and methods for treating stargardt disease - Google Patents WO2024229240A2 - Compositions and methods for treating stargardt disease - Google Patents Compositions and methods for treating stargardt disease Down…
WO2025147466A1 - Treatment for asymptomatic stargardt disease patients - Google Patents WO2025147466A1 - Treatment for asymptomatic stargardt disease patients - Google Patents Treatment for asymptomatic stargardt disease patients Download P…
US20060089411A1 - Treatment of Stargardt's disease and other lipofuscin disorders with combined retinaldehyde inhibitor and zeaxanthin - Google Patents US20060089411A1 - Treatment of Stargardt's disease and other lipofuscin disorder…
US9752119B2 - Substantially pure human retinal progenitor, forebrain progenitor, and retinal pigment epithelium cell cultures and methods of making the same - Google Patents US9752119B2 - Substantially pure human retinal progenitor, forebra…
US10519422B2 - Method of producing human retinal pigment epithelial cells - Google Patents US10519422B2 - Method of producing human retinal pigment epithelial cells - Google Patents Method of producing human retinal pigment epithelial cells…
US9328328B2 - Substantially pure human retinal progenitor, forebrain progenitor, and retinal pigment epithelium cell cultures and methods of making the same - Google Patents US9328328B2 - Substantially pure human retinal progenitor, forebra…
US20110269173A1 - Method for Producing Polarized Retinal Progenitor Cells from Pluripotent Stem Cells and their Differentiation into Retinal Pigment Epithelium Cells - Google Patents US20110269173A1 - Method for Producing Polarized Retinal…
WO2014121077A3 - METHOD FOR GENERATING RETINAL PIGMENT EPITHELIUM (RPE) CELLS FROM INDUCED PLURIPOTENT STEM CELLS (IPSCs) - Google Patents WO2014121077A3 - METHOD FOR GENERATING RETINAL PIGMENT EPITHELIUM (RPE) CELLS FROM INDUCED PLURIPOTEN…
US10246682B2 - Methods of culturing retinal pigmented epithelium cells, including Xeno-free production, RPE enrichment, and cryopreservation - Google Patents US10246682B2 - Methods of culturing retinal pigmented epithelium cells, including…
EP3754014A1 - Automated method for preparing retinal pigment epithelium cells - Google Patents EP3754014A1 - Automated method for preparing retinal pigment epithelium cells - Google Patents Automated method for preparing retinal pigment epi…
EP2279247A1 - Retinal pigment epithelial stem cells - Google Patents EP2279247A1 - Retinal pigment epithelial stem cells - Google Patents Retinal pigment epithelial stem cells Info Publication number EP2279247A1 EP2279247A1 EP09734972A EP09…
AU2014212230B2 - Method for generating retinal pigment epithelium (RPE) cells from induced pluripotent stem cells (iPSCs) - Google Patents AU2014212230B2 - Method for generating retinal pigment epithelium (RPE) cells from induced pluripoten…
WO2017044483A1 - Method for reproducible differentiation of clinical-grade retinal pigment epithelium cells - Google Patents WO2017044483A1 - Method for reproducible differentiation of clinical-grade retinal pigment epithelium cells - Googl…
WO2021050980A1 - Druggable target to treat retinal degeneration - Google Patents WO2021050980A1 - Druggable target to treat retinal degeneration - Google Patents Druggable target to treat retinal degeneration Download PDF Info Publication n…
WO2020070333A1 - Ezrin inhibitors and uses thereof - Google Patents WO2020070333A1 - Ezrin inhibitors and uses thereof - Google Patents Ezrin inhibitors and uses thereof Info Publication number WO2020070333A1 WO2020070333A1 PCT/EP2019/07711…
WO2015052256A1 - Tetrahydropyridoethers for the treatment of stargardt's disease - Google Patents WO2015052256A1 - Tetrahydropyridoethers for the treatment of stargardt's disease - Google Patents Tetrahydropyridoethers for the treat…